We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.65B
AUM Growth
+$213M
Cap. Flow
+$127M
Cap. Flow %
7.68%
Top 10 Hldgs %
13.99%
Holding
1,616
New
434
Increased
384
Reduced
359
Closed
375

Sector Composition

Rank Sector Weight
1 Technology 14.94%
2 Consumer Discretionary 9.59%
3 Healthcare 9.5%
4 Industrials 8.56%
5 Communication Services 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TS icon
551
Tenaris
TS
$27.4B
$601K 0.04%
18,895
TLT icon
552
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
$600K 0.04%
6,121
-8,136
-57% -$785K
PLAY icon
553
Dave & Buster's
PLAY
$346M
$600K 0.04%
17,632
+11,660
+195% +$398K
OHI icon
554
PUT
Omega Healthcare
OHI
$14.3B
$598K 0.04%
14,700
-200
-1% -$7.57K
BUR icon
555
Burford Capital
BUR
$935M
$598K 0.04%
45,097
+856
+2% +$11.4K
EQH icon
556
Equitable Holdings
EQH
$14.4B
$596K 0.04%
14,188
+407
+3% +$16.7K
KNF icon
557
Knife River
KNF
$3.84B
$595K 0.04%
6,653
+399
+6% +$31.2K
ITOT icon
558
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$594K 0.04%
+4,729
New +$573K
ABM icon
559
ABM Industries
ABM
$2.8B
$593K 0.04%
11,247
+4,560
+68% +$241K
KKR icon
560
KKR & Co
KKR
$93.4B
$593K 0.04%
4,540
-4,485
-50% -$531K
RARE icon
561
Ultragenyx Pharmaceutical
RARE
$2.66B
$592K 0.04%
10,660
+4,460
+72% +$227K
EWY icon
562
iShares MSCI South Korea ETF
EWY
$25.3B
$592K 0.04%
9,250
-8,750
-49% -$567K
CNTA
563
DELISTED
Centessa Pharmaceuticals
CNTA
$590K 0.04%
36,900
-32,000
-46% -$392K
SNDA icon
564
Sonida Senior Living
SNDA
$1.99B
$590K 0.04%
+22,063
New +$633K
UPST icon
565
Upstart Holdings
UPST
$2.96B
$587K 0.04%
+14,660
New +$488K
ANF icon
566
Abercrombie & Fitch
ANF
$5.27B
$586K 0.04%
+4,187
New +$637K
PVH icon
567
PVH
PVH
$4.02B
$585K 0.04%
5,804
+1,136
+24% +$113K
SMTC icon
568
Semtech
SMTC
$12.4B
$585K 0.04%
12,812
+5,605
+78% +$206K
AGR
569
DELISTED
Avangrid, Inc.
AGR
$583K 0.04%
16,293
-38,539
-70% -$1.38M
TTWO icon
570
Take-Two Interactive
TTWO
$47.3B
$581K 0.04%
3,781
+1,048
+38% +$159K
VNOM icon
571
Viper Energy
VNOM
$15.3B
$580K 0.04%
12,855
-1,790
-12% -$78.7K
TGNA
572
DELISTED
TEGNA Inc
TGNA
$579K 0.04%
36,682
-281
-0.8% -$4.1K
ARCC icon
573
PUT
Ares Capital
ARCC
$14.3B
$578K 0.04%
27,600
SKYY icon
574
First Trust Cloud Computing ETF
SKYY
$3.22B
$576K 0.03%
+5,630
New +$540K
RNG icon
575
RingCentral
RNG
$5.39B
$575K 0.03%
+18,168
New +$574K

Similar funds

Prelude Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Prelude Capital Management held 1,616 positions worth $1.65B, up 15% from $1.44B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $127M of net new capital in Q3 2024, opening 434 new positions and adding to 384 existing holdings. Its largest new stake was Kellanova: 90,625 shares worth $7.31M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Western Digital, an estimated $8.43M trimmed.

  • Prelude Capital Management's largest Q3 2024 buy was Kellanova: 90,625 shares worth $7.31M.
  • Prelude Capital Management added most to Elastic in Q3 2024, an estimated $6.65M increase.
  • Prelude Capital Management's biggest Q3 2024 reduction was Western Digital, cutting an estimated $8.43M.
  • Prelude Capital Management fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $11.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.65B portfolio in Q3 2024.
  • Prelude Capital Management opened 434 new positions and closed 375 in Q3 2024.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $1.65B.

Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.